19 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Deisseroth, Psychiatrist in Stanford, CA?
Dr. Karl Deisseroth, MD is a Psychiatrist, who primarily practices in Stanford, CA with 1 additional practice location. He has been practicing for over 19 years and is board certified. Dr. Deisseroth completed his residency at Stanford Univ Hosp, Psychiatry. Dr. Deisseroth is fluent in English and Spanish, and is currently seeing new patients. Dr. Deisseroth’s practice accepts Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Deisseroth’s office at (650) 498-5710.
Where did Dr. Deisseroth go to medical school and complete their residency?
Residency: Stanford Univ Hosp, Psychiatry | Stanford University Hospital
Medical School: Stanford Univ Sch Of Med- Stanford Ca
Is Dr. Deisseroth board certified as a Psychiatrist?
Yes, Dr. Karl Deisseroth, MD is board certified by the American Board of Psychiatry and Neurology
What languages does Dr. Deisseroth speak?
Dr. Deisseroth and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does a Psychiatrist like Dr. Deisseroth typically treat?
As a Psychiatrist, Dr. Deisseroth diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Deisseroth. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Depression
- Clinical depression
- Major depressive disorder
- Mood disorder
ICD-10 Codes:
- F32A: Depression, unspecified
What procedures does a Psychiatrist like Dr. Deisseroth typically perform?
As a Psychiatrist, procedures performed by Dr. Karl Deisseroth may include:
- Child Psychiatry Consultation
- Child Psychiatry Follow Up
- Cognitive Behavioral Therapy (CBT)
- Couples Therapy
- Electroconvulsive Therapy (ECT)
- Hypnotherapy
- Inpatient Psychiatric Services
- Ketamine Infusion
Please contact Dr. Deisseroth's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Deisseroth accept my insurance?
Dr. Deisseroth accepts most major insurance plans. Important: Please call our office at (650) 498-5710 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Deisseroth accept in Stanford, CA?
Dr. Deisseroth in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Blue Shield of California
Centene Corporation
Cigna Group
Medicare
Other Provider Networks
View All Insurances
Where is Dr. Deisseroth's office located?
Recognitions
Publications
Structural and molecular interrogation of intact biological systems.
, 2013
Diverging neural pathways assemble a behavioural state from separable features in anxiety
, 2013
Dopamine neurons modulate neural encoding and expression of depression-related behaviour
, 2013
A prefrontal cortex-brainstem neurol projection that controls response to behavioural challenge
, 2012
Crystal structure of the channelrhodopsin light-gated cation channel
, 2012
The Microbial Opsin Family of Optogenetic Tools
, 2011
Neocortical excitation/inhibition balance in information processing and social dysfunction
, 2011
Optogenetics in Neural Systems
, 2011
Amygdala circuitry mediating reversible and bidirectiol control of anxiety
, 2011
Optogenetics
, 2011
The Development and Application of Optogenetics
, 2011
Cholinergic Interneurons Control Local Circuit Activity and Cocaine Conditioning
, 2010
Parvalbumin neurons and gamma rhythms enhance cortical circuit performance
, 2009
Driving fast-spiking cells induces gamma rhythm and controls sensory responses
, 2009
Phasic Firing in Dopaminergic Neurons Is Sufficient for Behavioral Conditioning
, 2009
Temporally precise in vivo control of intracellular siglling
, 2009
Optical Deconstruction of Parkinsonian Neural Circuitry
, 2009
CLARITY for mapping the nervous system.
, 2013
Hypothalamic Neurotensin Projections Promote Reward by Enhancing Glutamate Transmission in the VTA
, 2013
Multiple Sources of Striatal Inhibition Are Differentially Affected
, 2013
Optogenetic Delay of Status Epilepticus Onset in an In Vivo Rodent Epilepsy Model
, 2013
Making Waves: Initiation and Propagation of Corticothalamic Ca2+ Waves In Vivo
, 2013
Making waves: initiation and propagation of corticothalamic Ca2+ waves in vivo.
, 2013
The Brain Activity Map
, 2013
Neuroscience. The brain activity map.
, 2013
notools for Neuroscience and Brain Activity Mapping
, 2013
Posttraining optogenetic manipulations of b
, 2013
Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons
, 2013
Glutamatergic Neurotransmission between the C1 Neurons
, 2013
Optogenetic Inhibition of Dorsal Medial Prefrontal Cortex Attenuates Stress
, 2013
Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical
, 2013
Cortico-Striatal Stimulation Generates Persistent OCD-Like Behavior.
, 2013
A unique population of ventral tegmental area neurons inhibits the lateral habenula to promote
A causal link between prediction errors, dopamine neurons and learning
Engineering approaches to illumiting brain structure and dymics.
Causal interactions between fronto-parietal central executive and default-mode networks in humans.
Optogenetics.
Light microscopy mapping of connections in the intact brain.
Optogenetics in the behaving rat: integration of diverse new technologies in a vital animal model.
Optogenetic activation of an inhibitory network enhances feedforward functiol connectivity
Optogenetic inhibition of cocaine seeking in rats
, 2013
Prefrontal D1 dopamine sigling is required for temporal control
, 2012
Two-photon optogenetic toolbox for fast inhibition, excitation and bistable modulation
, 2012
Two-photon optogenetics of dendritic spines and neural circuits
, 2012
Optogenetic and Potassium Channel Gene Therapy in a Rodent Model of Focal Neocortical Epilepsy
, 2012
Reversible online control of habitual behavior by optogenetic perturbation of medial prefrontal
, 2012
Input-specific control of reward and aversion in the ventral tegmental area
, 2012
High-Frequency Hippocampal Oscillations Activated by Optogenetic Stimulation of Transplanted Human
, 2012
Color-tuned Channelrhodopsins for Multiwavelength Optogenetics
, 2012
Neurol circuitry mechanism regulating adult quiescent neural stem-cell fate decision
, 2012
Photothermal Genetic Engineering
, 2012
Activation of specific interneurons improves V1 feature selectivity and visual perception
, 2012
When the electricity (and the lights) go out: transient changes in excitability
, 2012
Expanding the Repertoire of Optogenetically Targeted Cells with an Enhanced Gene Expression System
, 2012
Striatal Dopamine Release Is Triggered by Synchronized Activity in Cholinergic Interneurons
, 2012
Altered profile of basket cell afferent sypses in hyper
, 2012
Optogenetics and Psychiatry: Applications, Challenges, and Opportunities
, 2012
A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction
, 2012
Optogenetic stimulation of a hippocampal engram activates fear memory recall
, 2012
Syptic Activity Unmasks Dopamine D2 Receptor Modulation of a Specific Class of Layer V Pyramidal
, 2012
Optogenetic investigation of neural circuits underlying brain disease in animal models
, 2012
GABA Neurons of the VTA Drive Conditioned Place Aversion
, 2012
Structural Model of Channelrhodopsin
, 2012
Integrated device for combined optical neuromodulation
, 2012
Principles for applying optogenetic tools derived from direct comparative alysis of microbial
, 2012
Optetrode: a multichannel readout for optogenetic control in freely moving mice.
, 2012
GABAergic circuits mediate the reinforcement-related sigls of striatal cholinergic interneurons.
, 2012
GABAergic circuits mediate the reinforcement-related sigls of striatal cholinergic interneurons
, 2012
Optetrode: a multichannel readout for optogenetic control in freely moving mice
, 2012
A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction
, 2012
Recombise-Driver Rat Lines: Tools, Techniques
, 2011
Leptin regulates the reward value of nutrient
, 2011
Neurol filtering of multiplexed odour representations
, 2011
SNCA Triplication Parkinson's Patient's iPSC-derived DA Neurons Accumulate alpha-Synuclein
, 2011
Hemisphere-specific optogenetic stimulation reveals left-right asymmetry of hippocampal plasticity
, 2011
Dymics of Retrieval Strategies for Remote Memories
, 2011
Differential Modulation of Excitatory and Inhibitory Striatal Syptic Transmission by Histamine
, 2011
In Vivo Optogenetic Stimulation of Neocortical Excitatory Neurons Drives Brain-State
, 2011
Multiscale Computatiol Models for Optogenetic Control of Cardiac Function
, 2011
Cell type-specific channelrhodopsin
, 2011
A new mode of corticothalamic transmission revealed in the Gria4(-/-) model of absence epilepsy
, 2011
Optogenetic Interrogation of Dopaminergic Modulation of the Multiple Phases of Reward
, 2011
Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking
, 2011
OPTOGENETICS: BACKGROUND AND CONCEPTS FOR NEUROSURGERY
, 2011
Challenges and Opportunities for Next-Generation Intracortically Based Neural Prostheses
, 2011
High-efficiency channelrhodopsins for fast neurol stimulation at low light levels
, 2011
Functiol Integration of Grafted Neural Stem Cell
, 2011
An optogenetic toolbox designed for primates
, 2011
Active Expiration Induced by Excitation of Ventral Medulla in Adult Anesthetized Rats
, 2011
An Implantable Optical Stimulation Delivery System for Actuating an Excitable Biosubstrate
, 2011
Tracking Stem Cell Differentiation in the Setting of Automated Optogenetic Stimulation
, 2011
Optogenetics.
, 2011
Amygdala circuitry mediating reversible and bidirectiol control of anxiety.
, 2011
High-efficiency channelrhodopsins for fast neurol stimulation at low light levels.
Drug-Driven AMPA Receptor Redistribution Mimicked by Selective Dopamine Neuron Stimulation
, 2010
Tuning arousal with optogenetic modulation of locus coeruleus neurons
, 2010
Antidepressant Effect of Optogenetic Stimulation of the Medial Prefrontal Cortex
, 2010
Encoding of conditioned fear in central amygdala inhibitory circuits
, 2010
Genetic dissection of an amygdala microcircuit that gates conditioned fear
, 2010
Functiol Control of Transplantable Human ESC-Derived Neurons via Optogenetic Targeting
, 2010
Cell Type-Specific Loss of BDNF Sigling Mimics Optogenetic Control of Cocaine Reward
, 2010
Orderly recruitment of motor units under optical control in vivo
, 2010
Astrocytes Control Breathing Through pH-Dependent Release of ATP
, 2010
Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry
, 2010
Genetic Reactivation of Cone Photoreceptors Restores Visual Responses in Retinitis Pigmentosa
, 2010
Optical activation of lateral amygdala pyramidal cells instructs associative fear learning
, 2010
Global and local fMRI sigls driven by neurons defined optogenetically by type and wiring
, 2010
Glutamatergic Sigling by Mesolimbic Dopamine Neurons in the Nucleus Accumbens
, 2010
Dlx5 and Dlx6 Regulate the Development of Parvalbumin-Expressing Cortical Interneurons
, 2010
Molecular and Cellular Approaches for Diversifying and Extending Optogenetics
, 2010
Ultrafast optogenetic control
, 2010
Orderly recruitment of motor units under optical control in vivo.
, 2010
Targeted optogenetic stimulation
, 2010
Optogenetic interrogation of neural circuits: technology for probing mammalian brain structures
, 2010
Controlling the brain with light
, 2010
Optical activation of lateral amygdala pyramidal cells instructs associative fear leaJohansen JP
Special issue on optical neural engineering: advances in optical stimulation technology.
, 2010
Optogenetic dissection of neurol circuits in zebrafish using viral gene transfer and the Tet system
, 2009
Integrated device for optical stimulation
, 2009
Sleep Homeostasis Modulates Hypocretin-Mediated Sleep-to-Wake Transitions
, 2009
Optogenetic control of epileptiform activity
, 2009
Induced chromosome deletions cause hypersociability
, 2009
Bi-stable neural state switches
, 2009
Escape behavior elicited by single
, 2008
eNpHR: a tronomos halorhodopsin enhanced for optogenetic applications
, 2008
Improved expression of halorhodopsin for light-induced silencing of neurol activity
, 2008
Brain circuit dymics
, 2008
Red-shifted optogenetic excitation: a tool for fast neural control derived from Volvox carteri
, 2008
Controlling neurol activity
, 2008
Red-shifted optogenetic excitation: a tool for fast neural control derived from Volvox carteri.
, 2008
Brain circuit dymics
, 2008
Targeting and readout strategies for fast optical neural control in vitro and in vivo
, 2007
Nociceptive neurons protect Drosophila larvae from parasitoid wasps
, 2007
Neural substrates of awakening probed with optogenetic control of hypocretin neurons
, 2007
Integratio
What is Dr. Deisseroth's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Deisseroth's National Provider Identifier (NPI) number is 1902933310.
What common questions do patients ask about Dr. Deisseroth?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Deisseroth
What is Dr. Karl Deisseroth's specialty?
Dr. Deisseroth is a Psychiatrist near Stanford, CA.
What does a Psychiatrist do?
A Psychiatrist specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.